Maintenance rituximab vs azathioprine in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis who had undergone induction with cyclophosphamide + corticosteroids

Trial Profile

Maintenance rituximab vs azathioprine in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis who had undergone induction with cyclophosphamide + corticosteroids

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Nov 2016

At a glance

  • Drugs Rituximab (Primary) ; Azathioprine; Cyclophosphamide; Prednisone
  • Indications Microscopic polyangiitis; Wegener's granulomatosis
  • Focus Therapeutic Use
  • Acronyms MAINRITSAN
  • Most Recent Events

    • 25 Mar 2016 Results published in the Clinical and Experimental Rheumatology
    • 16 Dec 2013 New trial record
    • 30 Oct 2013 Results assessing rates of infections and immune parameters presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top